Anita Dushyanth
Stock Analyst at Berenberg
(2.58)
# 2,160
Out of 5,241 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $28.58 | -30.02% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $1.76 | +638.64% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.13 | +106,094.69% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $22.44 | +314.44% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $28.58
Upside: -30.02%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $1.76
Upside: +638.64%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.13
Upside: +106,094.69%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $22.44
Upside: +314.44%